Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Lung Neoplasms 10Small Cell Lung Carcinoma 6Thymoma 5Carcinoma, Renal Cell 4Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Thyroid Neoplasms 2Stomach Neoplasms 2Prostatic Neoplasms 2Gastrointestinal Stromal Tumors 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thymus Neoplasms 1Thoracic Neoplasms 1Somatostatinoma 1Recurrence 1Rectal Neoplasms 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Nervous System Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mesothelioma, Malignant 1Mesothelioma 1Melanoma 1Lymphoma 1

Interventions

glutathione pegylated liposomal doxorubicin 1Trastuzumab 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nervous System Neoplasms × Sunitinib × Thoracic × Clear all
NCT00437372 2025-05-02

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Thomas Jefferson University

Phase 1 Completed
39 enrolled
GynecologicHead & NeckThoracic

Head and Neck Neoplasms, Neoplasms, Nervous System Neoplasms, Pelvic Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡